VTYX Stock Analysis: Buy, Sell, or Hold?
VTYX - Ventyx Biosciences, Inc. Common Stock
$14.00
0.02 (0.14%)
▲
5d:
+0.29%
30d:
+0.36%
90d:
+40.0%
HOLD
MODERATE Confidence
Analysis Updated: Mar 3, 2026 12:00 AM ET
Earnings: May 07, 2026
Get Alerted When VTYX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VTYX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: VTYX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: VTYX is currently trading at $14.00, which is considered extended relative to its 30-day fair value range of $13.96 to $13.99.
Technical Outlook: Technically, VTYX is in a strong uptrend. The price is currently testing key support at $13.94. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VTYX is in a strong uptrend. The price is currently testing key support at $13.94. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$13.96 -
$13.99
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
55.0%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($13.29)
Fair Price Analysis
30-Day Fair Range
$13.96 -
$13.99
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$0.33
(2.3%)
Support & Resistance Levels
Support Level
$13.94
Resistance Level
$14.00
Current Trend
Strong Uptrend
Technical data as of
Mar 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.59
Wall Street Target
$13.29
(-5.1%)
Share & Embed Analysis
Last updated: April 02, 2026 4:16 AM ET
Data refreshes hourly during market hours. Next update: 5:16 AM
Data refreshes hourly during market hours. Next update: 5:16 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VTYX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
John Nuss
SELL
12675 shares
2025-12-18
Raju Mohan
SELL
47345 shares
2025-12-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$54 | 63 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 63 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 56 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 66 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 57 HOLD |
